Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial

• Main Authors: Rongrong Zou (Author), Ling Peng (Author), Dan Shu (Author), Lei Zhao (Author), Jianfeng Lan (Author), Guoyu Tan (Author), Jinghan Peng (Author), Xiangyi Yang (Author), Miaona Liu (Author), Chenhui Zhang (Author), Jing Yuan (Author), Huxiang Wang (Author), Song Li (Author), Hongzhou Lu (Author), Wu Zhong (Author), Yingxia Liu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The rapid worldwide spread of the Omicron variant of SARS-CoV-2 has unleashed a new wave of COVID-19 outbreaks. The efficacy of molnupiravir, an approved drug, is still unknown in patients infected with the Omicron variant.Objective: Evaluated the antiviral efficacy and safety of molnupi...